- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cell-Free DNA (cfDNA) Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cell-Free DNA (cfDNA) Testingmarket, defines the market attractiveness level of Cell-Free DNA (cfDNA) Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cell-Free DNA (cfDNA) Testing industry, describes the types of Cell-Free DNA (cfDNA) Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cell-Free DNA (cfDNA) Testing market and the development prospects and opportunities of Cell-Free DNA (cfDNA) Testing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cell-Free DNA (cfDNA) Testing market in Chapter 13.
By Player:
Natera
Guardant Health
Quest Diagnostics
Agilent Technology
Biodesix
Sequenom
Biocept
Allenex
Invited
Illumania
CareDx
Roche Holdings
Trovagene
By Type:
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
By End-User:
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cell-Free DNA (cfDNA) Testing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cell-Free DNA (cfDNA) Testing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cell-Free DNA (cfDNA) Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cell-Free DNA (cfDNA) Testing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cell-Free DNA (cfDNA) Testing Market Analysis and Outlook to 2022
-
7.1 Global Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.2 United States Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.3 Europe Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.4 China Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.5 Japan Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.6 India Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
-
7.7 South Korea Cell-Free DNA (cfDNA) Testing Consumption (2017-2022)
8 Region and Country-wise Cell-Free DNA (cfDNA) Testing Market Analysis and Outlook to 2028
-
8.1 Global Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.2 United States Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.3 Europe Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.4 China Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.5 Japan Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.6 India Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
-
8.7 South Korea Cell-Free DNA (cfDNA) Testing Consumption Forecast (2022-2028)
9 Global Cell-Free DNA (cfDNA) Testing Market Outlook by Types and Applications to 2022
-
9.1 Global Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Donor-Derived Cell-Free DNA (DdcfDNA) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Circulating Cell-Free Tumor DNA (CtDNA) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Cell-Free Fetal DNA (NIPT) Consumption and Growth Rate (2017-2022)
-
9.2 Global Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
10 Global Cell-Free DNA (cfDNA) Testing Market Outlook by Types and Applications to 2028
-
10.1 Global Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Donor-Derived Cell-Free DNA (DdcfDNA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Circulating Cell-Free Tumor DNA (CtDNA) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Cell-Free Fetal DNA (NIPT) Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
11 Global Cell-Free DNA (cfDNA) Testing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cell-Free DNA (cfDNA) Testing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cell-Free DNA (cfDNA) Testing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cell-Free DNA (cfDNA) Testing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cell-Free DNA (cfDNA) Testing Market Competitive Analysis
-
14.1 Natera
-
14.1.1 Natera Company Details
-
14.1.2 Natera Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Natera Cell-Free DNA (cfDNA) Testing Product and Service
-
14.2 Guardant Health
-
14.2.1 Guardant Health Company Details
-
14.2.2 Guardant Health Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Guardant Health Cell-Free DNA (cfDNA) Testing Product and Service
-
14.3 Quest Diagnostics
-
14.3.1 Quest Diagnostics Company Details
-
14.3.2 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product and Service
-
14.4 Agilent Technology
-
14.4.1 Agilent Technology Company Details
-
14.4.2 Agilent Technology Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Product and Service
-
14.5 Biodesix
-
14.5.1 Biodesix Company Details
-
14.5.2 Biodesix Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Biodesix Cell-Free DNA (cfDNA) Testing Product and Service
-
14.6 Sequenom
-
14.6.1 Sequenom Company Details
-
14.6.2 Sequenom Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sequenom Cell-Free DNA (cfDNA) Testing Product and Service
-
14.7 Biocept
-
14.7.1 Biocept Company Details
-
14.7.2 Biocept Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biocept Cell-Free DNA (cfDNA) Testing Product and Service
-
14.8 Allenex
-
14.8.1 Allenex Company Details
-
14.8.2 Allenex Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Allenex Cell-Free DNA (cfDNA) Testing Product and Service
-
14.9 Invited
-
14.9.1 Invited Company Details
-
14.9.2 Invited Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Invited Cell-Free DNA (cfDNA) Testing Product and Service
-
14.10 Illumania
-
14.10.1 Illumania Company Details
-
14.10.2 Illumania Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Illumania Cell-Free DNA (cfDNA) Testing Product and Service
-
14.11 CareDx
-
14.11.1 CareDx Company Details
-
14.11.2 CareDx Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 CareDx Cell-Free DNA (cfDNA) Testing Product and Service
-
14.12 Roche Holdings
-
14.12.1 Roche Holdings Company Details
-
14.12.2 Roche Holdings Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Product and Service
-
14.13 Trovagene
-
14.13.1 Trovagene Company Details
-
14.13.2 Trovagene Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cell-Free DNA (cfDNA) Testing
-
Figure Cell-Free DNA (cfDNA) Testing Picture
-
Table Global Cell-Free DNA (cfDNA) Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cell-Free DNA (cfDNA) Testing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cell-Free DNA (cfDNA) Testing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cell-Free DNA (cfDNA) Testing Consumption by Country (2017-2022)
-
Figure United States Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Table Europe Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Figure China Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Figure Japan Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Figure India Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cell-Free DNA (cfDNA) Testing Consumption and Growth Rate (2017-2022)
-
Figure Global Cell-Free DNA (cfDNA) Testing Consumption Forecast by Country (2022-2028)
-
Figure United States Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cell-Free DNA (cfDNA) Testing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Donor-Derived Cell-Free DNA (DdcfDNA) Consumption and Growth Rate (2017-2022)
-
Figure Global Circulating Cell-Free Tumor DNA (CtDNA) Consumption and Growth Rate (2017-2022)
-
Figure Global Cell-Free Fetal DNA (NIPT) Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Donor-Derived Cell-Free DNA (DdcfDNA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Circulating Cell-Free Tumor DNA (CtDNA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cell-Free Fetal DNA (NIPT) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cell-Free DNA (cfDNA) Testing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cell-Free DNA (cfDNA) Testing Export by Region (Top 5 Countries) (2017-2028)
-
Table Natera (Foundation Year, Company Profile and etc.)
-
Table Natera Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natera Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Guardant Health (Foundation Year, Company Profile and etc.)
-
Table Guardant Health Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Guardant Health Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Quest Diagnostics (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Agilent Technology (Foundation Year, Company Profile and etc.)
-
Table Agilent Technology Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Agilent Technology Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Biodesix (Foundation Year, Company Profile and etc.)
-
Table Biodesix Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biodesix Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Sequenom (Foundation Year, Company Profile and etc.)
-
Table Sequenom Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sequenom Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Biocept (Foundation Year, Company Profile and etc.)
-
Table Biocept Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biocept Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Allenex (Foundation Year, Company Profile and etc.)
-
Table Allenex Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allenex Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Invited (Foundation Year, Company Profile and etc.)
-
Table Invited Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Invited Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Illumania (Foundation Year, Company Profile and etc.)
-
Table Illumania Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Illumania Cell-Free DNA (cfDNA) Testing Product and Service
-
Table CareDx (Foundation Year, Company Profile and etc.)
-
Table CareDx Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table CareDx Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Roche Holdings (Foundation Year, Company Profile and etc.)
-
Table Roche Holdings Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holdings Cell-Free DNA (cfDNA) Testing Product and Service
-
Table Trovagene (Foundation Year, Company Profile and etc.)
-
Table Trovagene Cell-Free DNA (cfDNA) Testing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trovagene Cell-Free DNA (cfDNA) Testing Product and Service
-